Skip to Content

Continuing Education

2023 Year in Review: Updates in Therapy

Best Suited For: Pharmacist, Pharmacy Technician

CE Credits: 1 hours

Related Topics: New Drug Approvals, Clinical Trial Design, Medication Safety

Description

The purpose of this activity is to provide a general overview of the newly FDA approved therapies in 2023. Additionally, this activity will conduct a review of new oncology drugs, new indications, and withdrawals from the market. Among the new therapies that came to market, this activity will go in depth regarding approved indications, mechanisms of action, clinical trial data, and safety. The participants will gain knowledge and understanding of the newly approved therapies from 2023 and their place in clinical practice.

Pricing

This activity does not require payment to register.

This course has expired.

View our full list of NCODA courses or check the webinar recordings for more to discover.